A significant advance in cancer research is emerging with the use of mini-antibodies to reactivate damaged p53. This vital malignant protector protein is frequently disabled in many forms of tumors, leading https://peakbookmarks.com/story22028045/vhh-fragments-reactivate-p53-a-promising-pathway-for-tumor-treatment